Stock Analysis

Kinaxis Inc. Just Beat EPS By 23%: Here's What Analysts Think Will Happen Next

TSX:KXS
Source: Shutterstock

Kinaxis Inc. (TSE:KXS) shareholders are probably feeling a little disappointed, since its shares fell 8.8% to CA$155 in the week after its latest quarterly results. It looks like a credible result overall - although revenues of US$118m were what the analysts expected, Kinaxis surprised by delivering a (statutory) profit of US$0.12 per share, an impressive 23% above what was forecast. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

Check out our latest analysis for Kinaxis

earnings-and-revenue-growth
TSX:KXS Earnings and Revenue Growth August 2nd 2024

Following the latest results, Kinaxis' eleven analysts are now forecasting revenues of US$489.9m in 2024. This would be a satisfactory 7.0% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to swell 19% to US$0.88. In the lead-up to this report, the analysts had been modelling revenues of US$489.9m and earnings per share (EPS) of US$0.68 in 2024. Although the revenue estimates have not really changed, we can see there's been a considerable lift to earnings per share expectations, suggesting that the analysts have become more bullish after the latest result.

The consensus price target was unchanged at CA$195, implying that the improved earnings outlook is not expected to have a long term impact on value creation for shareholders. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. The most optimistic Kinaxis analyst has a price target of CA$228 per share, while the most pessimistic values it at CA$155. This shows there is still a bit of diversity in estimates, but analysts don't appear to be totally split on the stock as though it might be a success or failure situation.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. It's pretty clear that there is an expectation that Kinaxis' revenue growth will slow down substantially, with revenues to the end of 2024 expected to display 15% growth on an annualised basis. This is compared to a historical growth rate of 21% over the past five years. Juxtapose this against the other companies in the industry with analyst coverage, which are forecast to grow their revenues (in aggregate) 17% annually. Factoring in the forecast slowdown in growth, it looks like Kinaxis is forecast to grow at about the same rate as the wider industry.

The Bottom Line

The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around Kinaxis' earnings potential next year. They also reconfirmed their revenue estimates, with the company predicted to grow at about the same rate as the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple Kinaxis analysts - going out to 2026, and you can see them free on our platform here.

We don't want to rain on the parade too much, but we did also find 1 warning sign for Kinaxis that you need to be mindful of.

Valuation is complex, but we're here to simplify it.

Discover if Kinaxis might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.